233 related articles for article (PubMed ID: 23869143)
1. Prevalence of hepatic steatosis in women with polycystic ovary syndrome.
Karoli R; Fatima J; Chandra A; Gupta U; Islam FU; Singh G
J Hum Reprod Sci; 2013 Jan; 6(1):9-14. PubMed ID: 23869143
[TBL] [Abstract][Full Text] [Related]
2. Increased androgen bioavailability is associated with non-alcoholic fatty liver disease in women with polycystic ovary syndrome.
Vassilatou E; Lafoyianni S; Vryonidou A; Ioannidis D; Kosma L; Katsoulis K; Papavassiliou E; Tzavara I
Hum Reprod; 2010 Jan; 25(1):212-20. PubMed ID: 19887498
[TBL] [Abstract][Full Text] [Related]
3. Nonalcoholic fatty liver disease in women with polycystic ovary syndrome: associated factors and noninvasive fibrosis staging in a single Brazilian center.
Taranto DOL; Guimarães TCM; Couto CA; Cândido AL; Azevedo RCS; Mattos FS; Elias MLC; Reis FM; Rocha ALL; Faria LC
Arch Endocrinol Metab; 2020; 64(3):235-242. PubMed ID: 32555989
[TBL] [Abstract][Full Text] [Related]
4. Non-alcoholic fatty liver disease in women with polycystic ovary syndrome: assessment of non-invasive indices predicting hepatic steatosis and fibrosis.
Polyzos SA; Goulis DG; Kountouras J; Mintziori G; Chatzis P; Papadakis E; Katsikis I; Panidis D
Hormones (Athens); 2014; 13(4):519-31. PubMed ID: 25402369
[TBL] [Abstract][Full Text] [Related]
5. Increased prevalence of polycystic ovary syndrome in premenopausal women with nonalcoholic fatty liver disease.
Vassilatou E; Vassiliadi DA; Salambasis K; Lazaridou H; Koutsomitopoulos N; Kelekis N; Kassanos D; Hadjidakis D; Dimitriadis G
Eur J Endocrinol; 2015 Dec; 173(6):739-47. PubMed ID: 26340970
[TBL] [Abstract][Full Text] [Related]
6. Hepatic steatosis in women with polycystic ovary syndrome.
Hong X; Guo Z; Yu Q
BMC Endocr Disord; 2023 Sep; 23(1):207. PubMed ID: 37752440
[TBL] [Abstract][Full Text] [Related]
7. Nonalcoholic Fatty Liver Disease in a Sample of Iranian Women with Polycystic Ovary Syndrome.
Mehrabian F; Jahanmardi R
Int J Prev Med; 2017; 8():79. PubMed ID: 29114377
[TBL] [Abstract][Full Text] [Related]
8. Fibroscan as a non-invasive predictor of hepatic steatosis in women with polycystic ovary syndrome.
Chakraborty S; Ganie MA; Masoodi I; Jana M; ; Gupta N; Sofi NY
Indian J Med Res; 2020 Apr; 151(4):333-341. PubMed ID: 32461397
[TBL] [Abstract][Full Text] [Related]
9. Hepatic steatosis in young lean insulin resistant women with polycystic ovary syndrome.
Markou A; Androulakis II; Mourmouris C; Tsikkini A; Samara C; Sougioultzis S; Piaditis G; Kaltsas G
Fertil Steril; 2010 Mar; 93(4):1220-6. PubMed ID: 19171337
[TBL] [Abstract][Full Text] [Related]
10. Prevalence of nonalcoholic fatty liver disease in women with polycystic ovary syndrome.
Gambarin-Gelwan M; Kinkhabwala SV; Schiano TD; Bodian C; Yeh HC; Futterweit W
Clin Gastroenterol Hepatol; 2007 Apr; 5(4):496-501. PubMed ID: 17287148
[TBL] [Abstract][Full Text] [Related]
11. Abdominal Obesity as a Predictive Factor of Nonalcoholic Fatty Liver Disease Assessed by Ultrasonography and Transient Elastography in Polycystic Ovary Syndrome and Healthy Women.
Tantanavipas S; Vallibhakara O; Sobhonslidsuk A; Phongkitkarun S; Vallibhakara SA; Promson K; Sophonsritsuk A
Biomed Res Int; 2019; 2019():9047324. PubMed ID: 31467918
[TBL] [Abstract][Full Text] [Related]
12. Visceral adiposity index for the diagnosis of nonalcoholic fatty liver disease in premenopausal women with and without polycystic ovary syndrome.
Vassilatou E; Lafoyianni S; Vassiliadi DA; Ioannidis D; Paschou SA; Mizamtsidi M; Panagou M; Vryonidou A
Maturitas; 2018 Oct; 116():1-7. PubMed ID: 30244768
[TBL] [Abstract][Full Text] [Related]
13. The Burden of Non-Alcoholic Fatty Liver Disease in Adolescents with Polycystic Ovary Syndrome: A Case-Control Study.
Giannouli A; Efthymiou V; Konidari M; Mani I; Aravantinos L; Dourakis SP; Antoniou A; Deligeoroglou E; Bacopoulou F
J Clin Med; 2023 Jan; 12(2):. PubMed ID: 36675485
[TBL] [Abstract][Full Text] [Related]
14. Insulin resistance and hyperandrogenemia independently predict nonalcoholic fatty liver disease in women with polycystic ovary syndrome.
Harsha Varma S; Tirupati S; Pradeep TVS; Sarathi V; Kumar D
Diabetes Metab Syndr; 2019; 13(2):1065-1069. PubMed ID: 31336445
[TBL] [Abstract][Full Text] [Related]
15. Nonalcoholic fatty liver disease in women with polycystic ovary syndrome.
Cerda C; Pérez-Ayuso RM; Riquelme A; Soza A; Villaseca P; Sir-Petermann T; Espinoza M; Pizarro M; Solis N; Miquel JF; Arrese M
J Hepatol; 2007 Sep; 47(3):412-7. PubMed ID: 17560682
[TBL] [Abstract][Full Text] [Related]
16. An association between non-alcoholic fatty liver disease and polycystic ovarian syndrome.
Brzozowska MM; Ostapowicz G; Weltman MD
J Gastroenterol Hepatol; 2009 Feb; 24(2):243-7. PubMed ID: 19215335
[TBL] [Abstract][Full Text] [Related]
17. Nonalcoholic fatty liver disease and polycystic ovary syndrome.
Vassilatou E
World J Gastroenterol; 2014 Jul; 20(26):8351-63. PubMed ID: 25024594
[TBL] [Abstract][Full Text] [Related]
18. Non-alcoholic fatty liver disease in women with polycystic ovary syndrome: systematic review and meta-analysis.
Rocha ALL; Faria LC; Guimarães TCM; Moreira GV; Cândido AL; Couto CA; Reis FM
J Endocrinol Invest; 2017 Dec; 40(12):1279-1288. PubMed ID: 28612285
[TBL] [Abstract][Full Text] [Related]
19. Non-alcoholic fatty liver disease in women with polycystic ovary syndrome - clinical and metabolic aspects and lipoprotein lipase gene polymorphism.
Bohdanowicz-Pawlak A; Lenarcik-Kabza A; Brona A; Kuliczkowska-Płaksej J; Łaczmański Ł; Zaleska-Dorobisz U; Milewicz A
Endokrynol Pol; 2014; 65(6):416-21. PubMed ID: 25554608
[TBL] [Abstract][Full Text] [Related]
20. Adverse metabolic phenotype of adolescent girls with non-alcoholic fatty liver disease plus polycystic ovary syndrome compared with other girls and boys.
Ayonrinde OT; Adams LA; Doherty DA; Mori TA; Beilin LJ; Oddy WH; Hickey M; Sloboda DM; Olynyk JK; Hart R
J Gastroenterol Hepatol; 2016 May; 31(5):980-7. PubMed ID: 26589977
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
